종양학 정보 시스템 시장 : 제품, 용도 및 최종 사용자별 - 세계 예측(-2030년)

Oncology Information Systems Market Size, Share, Forecast, & Trends Analysis by Offering (Software {Patient Information, Treatment Planning}, Services), Application (Surgical, Radiology Oncology), End User (Hospital, Cancer Care) - Global Forecast to 2030

The oncology information systems market is projected to reach $4.45 billion by 2030 at a CAGR of 7.4% from 2023 to 2030.

Succeeding extensive secondary and primary research and an in-depth analysis of the market scenario, the report provides an analysis of key industry drivers, restraints, opportunities, and challenges.

The growth of this market is driven by the increasing prevalence of cancer, rising digitalization in cancer treatment, the growing need to reduce oncology care costs, the increasing adoption of Electronic Health Records (EHR), and the growing demand for streamlined patient information and data management.

However, the high cost of oncology information systems and data security and privacy concerns are restraining the growth of this market. In addition, the integration of precision medicine into cancer treatment and its growing potential in emerging countries are expected to generate significant growth opportunities for the players in this market.

However, barriers to the adoption and implementation of oncology information systems and additional requirements for training and education for using oncology information systems are major challenges limiting the market's growth.

The report offers a competitive landscape based on an extensive assessment of the product portfolios, geographic presence, and key strategic developments of leading market players during the last four years (2020-2023). The key players operating in the oncology information systems market are Accuray Incorporated (U.S.), Brainlab AG (Germany), DOSIsoft SA (France), Elekta AB (Sweden), Koninklijke Philips N.V. (Netherlands), MIM Software Inc. (U.S.), Oracle Corporation (U.S.), Prowess Inc. (U.S.), RaySearch Laboratories (Sweden), Siemens Healthcare GmbH (Germany), McKesson Corporation (U.S.), Altai, Inc (Turkey), and ViewRay Inc. (U.S.).

Based on offering the oncology information systems market is segmented into software and services. In 2023, the software segment is expected to account for the larger share of the oncology information systems market. The large share of this segment is attributed to the increased need to streamline patient data, the high prevalence of cancer, and the benefits of advanced features of oncology information systems such as management of patient treatment schedules, treatment plans, treatment delivery, and treatment summaries.

Based on application, the oncology information systems market is segmented into medical oncology, radiation oncology, and surgical oncology. In 2023, the medical oncology segment is expected to account for the largest share of the oncology information systems market. The large market share of this segment is attributed to the large number of patients receiving medical oncology treatments such as chemotherapy, immunotherapy, hormone therapy, and targeted therapy.

Based on end user, the oncology information systems market is segmented into hospitals, diagnostic imaging centers, cancer care centers, and other end users. In 2023, the hospitals segment is expected to account for the largest share of the oncology information systems market. The large market share of this segment is attributed to high healthcare expenditure, increased capability of hospitals to purchase and implement oncology information systems, and increased number of cancer patients relying on hospitals for treatment.

An in-depth analysis of the geographical scenario in the oncology information systems market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the oncology information systems market. North America's major market share is primarily attributed to the robust healthcare infrastructure, high healthcare expenditure, large patient population, high adoption of precision medicine, and the presence of key market players in the region.

Scope of the Report:

Oncology Information Systems Market Assessment-by Offering

• Software
  • Patient Information Systems
  • Treatment Planning Systems
• Services

Oncology Information Systems Market Assessment-by Application

• Radiation Oncology
• Medical Oncology
• Surgical Oncology

Oncology Information Systems Market Assessment-by End User

• Hospitals
• Diagnostic Imaging Centers
• Cancer Care Centers
• Other End Users

Note: Other end users primarily include research institutes and government institutions.

Oncology Information Systems Market Assessment-by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia-Pacific
  • China
  • Japan
  • India
  • Rest of Asia-Pacific (RoAPAC)
• Latin America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition & Scope
• 1.2. Market Ecosystem
• 1.3. Currency and Limitations
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Approach
• 2.2. Process of Data Collection & Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
• 2.3. Market Sizing and Forecast
  • 2.3.1. Market Size Estimation Approach
  • 2.3.2. Growth Forecast Approach
  • 2.3.3. Market Share Analysis
• 2.4. Assumptions for this Study

3. Executive Summary

4. Market Insights

• 4.1. Market Overview
• 4.2. Drivers
  • 4.2.1. Increasing Prevalence of Cancer
  • 4.2.2. Rising Digitalization in Cancer Treatment
  • 4.2.3. Rising Need to Reduce Oncology Care Costs
  • 4.2.4. Increasing Adoption of Electronic Health Records (EHRs)
  • 4.2.5. Increased Demand for Streamlined Patient Information and Data Management
• 4.3. Restraints
  • 4.3.1. High Cost of Oncology Information Systems
  • 4.3.2. Data Security and Privacy Concerns
• 4.4. Opportunities
  • 4.4.1. Integration of Precision Medicine for Cancer Treatment
  • 4.4.2 Potential in Emerging Countries
• 4.5. Challenges
  • 4.5.1. Barriers to Adoption and Implementation
  • 4.5.2. Additional Requirement for Training and Education for Using Oncology Information Systems
• 4.6. Pricing Analysis
• 4.7. Regulatory Analysis
• 4.8. Case Studies
• 4.9. Industry & Technology Trends

5. Global Oncology Information Systems Market Assessment-by Offering

• 5.1. Overview
• 5.2. Software
  • 5.2.1. Patient Information Systems
  • 5.2.2. Treatment Planning Systems
• 5.3. Services

6. Global Oncology Information Systems Market Assessment-by Application

• 6.1. Overview
• 6.2. Radiation Oncology
• 6.3. Medical Oncology
• 6.4. Surgical Oncology

7. Global Oncology Information Systems Market Assessment-by End User

• 7.1. Overview
• 7.2. Hospitals
• 7.3. Diagnostic Imaging Centers
• 7.4. Cancer Care Centers
• 7.5. Other End Users

8. Oncology Information Systems Market Assessment-by Geography

• 8.1. Overview
• 8.2. North America
  • 8.2.1. U.S.
  • 8.2.2. Canada
• 8.3. Europe
  • 8.3.1. Germany
  • 8.3.2. U.K.
  • 8.3.3. France
  • 8.3.4. Italy
  • 8.3.5. Spain
  • 8.3.6. Rest of Europe
• 8.4. Asia-Pacific
  • 8.4.1. China
  • 8.4.2. Japan
  • 8.4.3. India
  • 8.4.4. Rest of Asia-Pacific
• 8.5. Latin America
• 8.6. Middle East & Africa

9. Competition Analysis

• 9.1. Overview
• 9.2. Key Growth Strategies
• 9.3. Vendor Benchmarking
• 9.4. Competitive Dashboard
  • 9.4.1. Industry Leaders
  • 9.4.2. Market Differentiators
  • 9.4.3. Vanguards
  • 9.4.4. Emerging Companies
• 9.5. Market Share Analysis (2022)

10. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)

• 10.1. Accuray Incorporated
• 10.2. Brainlab AG
• 10.3. DOSIsoft SA
• 10.4. Elekta AB
• 10.5. Koninklijke Philips N.V.
• 10.6. MIM Software Inc.
• 10.7. Oracle Corporation
• 10.8. Prowess Inc.
• 10.9. RaySearch Laboratories
• 10.10. Siemens Healthcare GmbH
• 10.11. ViewRay Inc.
• 10.12. McKesson Corporation
• 10.13. Altai, Inc.

(Note: SWOT Analysis Of The Top 5 Players Will Be Provided In The Report)

11. Appendix

• 11.1. Available Customization
• 11.2. Related Reports